1. Introduction {#sec1}
===============

Infections of domestic and wild animals that are transmitted directly or by indirect means to humans are a major cause of morbidity and mortality worldwide, including in Nigeria, the nation with the largest population and economy in Africa \[[@bib1]\]. Approximately 60% of the 1,500 or more infectious microorganisms that are known human pathogens are recognized as zoonotic, i.e. they normally exist in animals but they can also infect people \[[@bib2], [@bib3]\]. While around 73% of currently emerging and re-emerging pathogenic agents cause zoonoses \[[@bib2], [@bib3]\], even more common infectious diseases of great importance to global public health, such as HIV/AIDS and malaria, are known to have emerged from zoonotic origins \[[@bib2]\]. It has thus been speculated that present and future generations may face the highest risk of exposure to zoonotic infections in human history, requiring us to address the impact this may have on life expectancy and quality of health \[[@bib2], [@bib3]\].

Bacterial zoonoses such as bubonic plague and bovine tuberculosis exacted an extremely heavy toll on humankind in the medieval period, a time prior to the introduction of acceptable hygiene practices and the advent of vaccines and antibiotics. In this light, the present growing emergence and spread of bacterial zoonoses has generated worldwide concern, with animals commonly identified as reservoir hosts shown to harbour a great diversity of potential pathogens \[[@bib3]\]. It is estimated that the livelihood of more than 600 million people globally is livestock-dependent. These communities represent up to 70% of the marginalized and poor population that is most exposed to the risk of zoonoses but which is typically isolated from delivery of adequate healthcare \[[@bib4]\].

Bacterial zoonoses represent a class of often-neglected human infections that may be responsible for a significant proportion of febrile illnesses without localizing features, especially in malaria-endemic areas of sub-Sahara Africa where frequently they may be misdiagnosed as the more prevalent protozoan infections \[[@bib5]\]. Although there are no published estimates of incidence of fever of unknown origin (FUO) in Nigeria the condition remains a challenging medical problem and reports have shown indications of common occurrence and subsequent misdiagnoses in aetiological determination \[[@bib6], [@bib7]\]. Notwithstanding the prevalence of FUO, potentially important fever-causing pathogens have not been investigated rigorously in many low- and middle-income nations, especially in rural locations, despite the apparent exposure of humans to animal reservoirs and vectors of zoonotic infections \[[@bib8]\]. A comprehensive understanding of preventable and treatable infectious causes of severe febrile illness is crucial to realizing a degree of disease control in developing countries and to improving outcomes in resident healthcare-seeking patients \[[@bib8]\].

This review discusses neglected zoonotic bacterial pathogens in Nigeria, West Africa. The focus is on common emerging and re-emerging zoonoses, drawing on notable developments in the field from recent global research, highlighting novel findings from those Nigerian studies conducted to date and identifying key aspects of their epidemiology that are not yet described in local investigations. We particularly highlight important bacterial zoonoses for which insights into transmission have not advanced in Nigeria as rapidly as elsewhere in the world. Most of these zoonotic diseases have also been identified as potentially significant contributors to cases of febrile illness in other parts of malaria-endemic sub-Sahara Africa \[[@bib5]\]. Embracing the One Health concept to combat bacterial zoonoses in Nigeria fosters a collaborative, multisectoral and transdisciplinary approach to human and animal health management and interventions, the principles of which can be applied in similar low-income contexts elsewhere.

2. Main text {#sec2}
============

2.1. Emerging and re-emerging bacterial zoonoses of notable public health importance in Nigeria {#sec2.1}
-----------------------------------------------------------------------------------------------

Since they are often associated with a high case fatality rate, zoonoses dominate Nigeria\'s register of infectious diseases for which emergency notification of incidence is required \[[@bib9]\]. Notifiable zoonoses in Nigeria include anthrax, plague, Lassa fever, Ebola virus disease, rabies, trypanosomiasis, salmonellosis, tuberculosis, influenza and yellow fever, most of which are considered endemic in the country \[[@bib1], [@bib9], [@bib10]\]. Sporadic cases of other zoonotic infections such as leptospirosis, scabies, pentastomiasis and African histoplasmosis are additionally thought to occur \[[@bib1]\]. Cryptosporidiosis and food-borne *Campylobacter* and *Escherichia coli* O157:H7 infections also constitute nationally important zoonoses \[[@bib1]\]. Throughout the developing world, neglected zoonotic diseases are considered endemic, with an inherent capacity to result in localized outbreaks and larger epidemics \[[@bib11]\].

Bacterial zoonotic infections have a remarkable potential to re-emerge after being considered as eradicated or under control, and thus they pose serious and continual threats to public health \[[@bib3]\]. Sometimes a bacterial zoonosis may also emerge newly in an area where it was previously unknown. For instance, the isolation of the Gram-negative bacterial zoonotic agent *Candidatus Neoehrlichia mikurensis* from 4% of the dog tick pools collected from four states in Nigeria is its first known description in Africa \[[@bib12]\]. The emergence and re-emergence of bacterial zoonoses have been attributed to a combination of climatic, ecological, agricultural and socio-economic factors that create an uncertain public health situation \[[@bib1]\]. The scenario presented is of an increasing risk of bacterial zoonotic infections to public health in Nigeria. However, here -- as across a large geographical footprint of the developing world \[[@bib8]\] -- fewer studies are conducted to investigate this class of zoonosis than most other infectious agents.

### 2.1.1. Bartonellosis {#sec2.1.1}

Bartonellae are facultative intracellular, fastidious, bacteria that infect both erythrocytes and endothelial cells, employing a silent strategy to prevent their rapid clearance by the host\'s immune system \[[@bib13]\]. More than 30 species of this group of Gram-negative bacteria are currently known, many of which were described only recently. This includes a growing number of *Bartonella* species recognized as human pathogens responsible for a variety of clinical manifestations \[[@bib14]\].

Species of *Bartonella* such as *B. elizabethae* and *B. grahamii*, known to cause human diseases in Peru and Thailand \[[@bib13], [@bib15]\], were identified in 26% of commensal rodents in a study conducted in Jos, the capital city of Plateau State, Nigeria \[[@bib16]\]. Another investigation detected DNA of *Bartonella* spp. in Nigeria similar to those revealed in Ghana and Kenya in 51.4% of bat blood samples screened \[[@bib7]\]. An apparently new species of the bacterium, named *B. rousetti*, was reported recently in Ondo State, Nigeria, with indications of ongoing human infection in Idanre communities \[[@bib14]\]. The infection prevalence among inhabitants was approximately 4%. To date, this is the only known report of possible human infection with bartonellosis in Nigeria.

Immunosuppression arising from varied causes such as cancer treatment, pregnancy, organ transplant, diabetes, alcoholism and even infancy is identified as an important risk factor for humans to contract bartonellosis and other bacterial zoonotic infections \[[@bib3]\].

### 2.1.2. Brucellosis {#sec2.1.2}

*Brucella* spp. are Gram-negative, facultative coccobacilli. Brucellosis remains a major neglected zoonotic disease of low-income nations. Although assessments of existing data suggest ongoing transmission of human brucellosis in Nigeria, information on the causative *Brucella* species is not sufficiently clear from the limited bacteriological studies \[[@bib11], [@bib17]\]. To date, reports of human infections are restricted to serological detection of human antibodies ([Table 1](#tbl1){ref-type="table"}), and this may not provide clear representation of the distribution of human infection by *B. abortus* or *B. melitensis* \[[@bib17]\]. Zoonotic infection with *Brucella* is associated with handling of wild and domestic animals, providing opportunity for direct transmission to occur \[[@bib17]\]. Consumption of raw or unpasteurized milk also constitutes an important transmission route for *Brucella* spp. \[[@bib17]\].Table 1Reports of human infection with important bacterial zoonoses in Nigeria.Table 1ZoonosisYear of ReportLocationStudy SubjectsSpecies/SerovarsPrevalenceBartonellosis2018 \[[@bib14]\]IdanreCommunity residents*Bartonella rousetti*3.9% (8/204)Brucellosis1974 \[[@bib106]\] [∗](#tbl1fnlowast){ref-type="table-fn"}Unavailable1976 \[[@bib107]\] [∗](#tbl1fnlowast){ref-type="table-fn"}Western NigeriaDairy farmers, slaughter men, general population*Brucella abortus*\>55.0%1977 \[[@bib108]\]Northern and Western NigeriaBlood donors, ante-natal patients, abattoir workers, veterinarians, dairy farmers, herdsmen*B. abortus*59.2% (1186/2010)1979 \[[@bib109]\]IbarapaHerdsmen, abattoir workers, high school students*B. abortus*35.6% (103/289)1980 \[[@bib110]\]IbadanLivestock farmers*B. abortus*5.9%1987 \[[@bib111]\]Minna and Abeokuta*B. abortus*9.0%*B. melitensis*11.7%1993 \[[@bib112]\] [∗](#tbl1fnlowast){ref-type="table-fn"}MaiduguriUnavailable1996 \[[@bib113]\]Calabar18.3%2001 \[[@bib114]\]MaiduguriPatients*B. abortus*5.2% (26/500)2006 \[[@bib115]\]IbadanButchers, abattoir workers, herdsmen*Brucella* spp.33.3% (7/21)2008 \[[@bib116]\]SokotoPrison inmates*B. abortus*, *B. melitensis*7.1% (2/28)2010 \[[@bib117]\]JosAbattoir workers*Brucella* spp.5.0% (5/101)2014 \[[@bib118]\]MakurdiPatients*B. abortus*, *B. melitensis*7.6% (79/1040)Leptospirosis1991 \[[@bib20]\]PlateauVolunteers*Leptospira pomona, L. canicola,*\
*L. grippotyphosa,*\
*L. hardjo, L. pyrogenes,*\
*L. icterohaemorrhagiae, L. autumnalis*18.0% (128/710)1993 \[[@bib21]\]EnuguCoal miners, butchers, abattoir workers, local farmers, hospital laboratory personnel*L. canicola, L. pomona, L. icterohaemorrhagiae, L. hardjo, L. pyrogenes, L. autumnalis,*\
*L. grippotyphosa*13.5% (89/661)2001 \[[@bib22]\]Nigeria (countrywide)20.4%2013 \[[@bib19]\]AbujaKennel workers*L*. *interrogans*50.0% (10/20)Q fever1959 \[[@bib119]\]IbadanBlood donors*Rickettsia burnetii*3.7% (12/323)1987 \[[@bib111]\]Minna and AbeokutaPatients*Coxiella burnetii*63.3%1990 \[[@bib120]\]SokotoPatients*C. burnetii*44.0% (33/75)Rickettsiosis1947 \[[@bib121]\]JosPatients89.1% (82/92)1978 \[[@bib122]\] [∗](#tbl1fnlowast){ref-type="table-fn"}EnuguPatientsUnavailable1987 \[[@bib111]\]Minna and AbeokutaPatients*Rickettsia conorii*18.6%2008 \[[@bib123]\]JosInmates*R. typhi*71.1%Salmonellosis1958 \[[@bib124]\] [∗](#tbl1fnlowast){ref-type="table-fn"}IbadanPatientsNTSUnavailable1959 \[[@bib125]\]IbadanBlood donors, patients74 NTS9.5% (200/2117)1960 \[[@bib126]\] [∗](#tbl1fnlowast){ref-type="table-fn"}Ibadan, Lagos and JosPatients, villagers*Salmonella enterica* serotypes: *S.* Dublin, *S*. Enteritidis, *S*. Typhimurium, *S*. Chailey, *S*. Stanleyville, *S*. Stockholm, *S*. Aminatu, *S*. Ank, *S*. Agama, *S*. Kaapstad, *S*. Aequotoria, *S*. Nigeria, *S*. Oranienburg, *S*. Virchow, *S*. Utah, *S*. Wangata, *S*. Oxford, *S*. Rubislaw, *S*. Tel-Elkebir, *S*. Brazil, *S*. Infantis, *S*. Dakar, *S*. Offa, *S*. Marseille, *S*. LoengaUnavailable1983 \[[@bib127]\]LagosPatients*S*. Typhimurium1.2% (12/994)*S*. Enteritidis0.3% (3/994)*S*. Oranienburg0.91% (9/994)1988 \[[@bib128]\]Abeokuta*S.* Mbandaka, *S.* Gold Coast, *S.* Durham,\
*S.* Antsalova, *S.* Wippra, *S.* Agama, *S.* Isangi4.2% (9/216)1994 \[[@bib129]\]LagosPaediatric patients*S*. Typhimurium1.3% (4/315)1995 \[[@bib130]\]Southeast NigeriaPatients*S.* Typhimurium,\
*S.* Enteritidis, *S.* Hardar, *S.* Virchow, *S.* Bredeney, non-typeable strains7.4% (60/809)2000 \[[@bib131]\]LagosPatients*S.* Arizonae2.5% (16/635)2002 \[[@bib132]\]NsukkaPatients11.0% (55/500)2005 \[[@bib133]\] [∗](#tbl1fnlowast){ref-type="table-fn"}ZariaPatientsNTSUnavailable2007 \[[@bib134]\]LagosPatients*S.* Enteritidis,\
*S.* Arizonae10.2% (45/441)2008 \[[@bib135]\]LagosPatients[Blood]{.ul} (*S.* Typhimurium, *S.* Enteritidis)3.0% (6/201)[Stool]{.ul} (*S.* Typhimurium)6.3% (3/48)2008 \[[@bib136]\]LagosFood vendors*S.* Enteritidis7.6% (4/53)2009 \[[@bib137]\]IbadanPaediatric patients*S.* Typhimurium0.08% (1/1210)2010 \[[@bib45]\]IbadanPatients*S.* Enteritidis, *S.* Dublin, *S.* Typhimurium*,*\
*S.* Jukestown,\
*S.* Monschaui,\
*S.* Oritamerin, *S.* Apapa3.2% (32/991)2010 \[[@bib138]\]LagosPatients4.3% (6/140)2011 \[[@bib91]\]AbujaPaediatric patientsNTS0.8% (8/969)2012 \[[@bib139]\]LagosPatientsNTS64.5% (54919/85187)2013 \[[@bib103]\]MaiduguriPatients*S.* Hadar, *S.* Eko,\
*S.* Enteritidis, *S.* Give,\
*S.* Uganda, *S.* Amager,\
*S.* Verviers,\
*Salmonella* 47:mt:-5.5% (27/490)2014 \[[@bib140]\]LagosPatients*S.* Enteritidis1.9% (2/105)2015 \[[@bib141]\]Kano and AbujaPaediatric patientsNTS0.9% (94/10133)2017 \[[@bib142]\]IbadanPatients*S.* Colindale, *S.* Agama, *S.* Bredney, *S.* Butantan, *S.* Chandans, *S.* Corvallis, *S.* Dakar, *S.* Gatehead, *S.* Give, *S.* Kentucky, *S.* Kibusi, *S.* Liverpool, *S.* Nigeria, *S.* Oranienburg, *S.* Poona, *S.* Typhimurium, *S.* Rubislaw, *S.* Urbana, *Salmonella* 4,5,12:i:-, *Salmonella* 43:d:-, *Salmonella* 6,7,d7.6% (30/394)2019 \[[@bib143]\]LagosFood handlers*S.* Limete, *S.* Portland,\
*S.* Huettwillen,\
*S.* Mowanjum,\
*S.* Typhimurium,\
*S.* Takoradi, *S.* Chagoua1.96% (7/358)Yersiniosis1982 \[[@bib100]\]ZariaPatients*Yersinia enterocolitica*21.3% (10/47)1983 \[[@bib127]\]LagosPatients*Y. enterocolitica*1.4% (14/994)1983 \[[@bib144]\]LagosPatients*Y. enterocolitica*0.55% (6/1082)1986 \[[@bib145]\]Lagos and JosPatients*Y. enterocolitica*9.9% (99/1000)1987 \[[@bib146]\]Minna and AbeokutaPatients*Yersinia* spp.16.4%1987 \[[@bib147]\]Ile-IfePupils*Y. enterocolitica*4.3% (32/752)1990 \[[@bib148]\]CalabarPatients*Y. enterocolitica*1.0%1992 \[[@bib149]\]LagosPatients*Yersinia* spp*.*1.4%1992 \[[@bib150]\]IbadanPatients*Y. enterocolitica*3.8% (8/210)1993 \[[@bib151]\]EnuguPatients*Y. enterocolitica*1.4% (9/638)1994 \[[@bib129]\]LagosPaediatric patients*Y. enterocolitica*0.6% (2/315)1996 \[[@bib152]\] [∗](#tbl1fnlowast){ref-type="table-fn"}LagosPatients*Y. enterocolitica*\<0.6%1997 \[[@bib153]\]Edo, Lagos and Cross RiverPatients*Y. enterocolitica*1.9% (45/2400)2009 \[[@bib55]\]PlateauPatients*Y. enterocolitica,*\
*Y. pseudotuberculosis*5.8% (29/500)[^1][^2]

### 2.1.3. Leptospirosis {#sec2.1.3}

In a study of risk factors for *Leptospira* infection published in 2015 a trend towards disease outbreak in Nigeria was reported for this zoonotic pathogen, a Gram-negative, obligate aerobe spirochaete \[[@bib18]\]. Leptospirosis is an important bacterial zoonosis with a significant level of sporadic occurrences, especially in northern Nigeria where animal husbandry is common \[[@bib1]\]. A national average incidence of six clinical cases of leptospirosis is reported annually, which is considered to be an underestimate \[[@bib19]\]. In Plateau and Enugu States, human infection rates of 18.0% and 13.5%, respectively, were detected in epidemiological surveys reported between 1991 and 1993 \[[@bib20],[@bib21]\], while a more recent countrywide investigation in 2001 reported a prevalence of 20.4% \[[@bib22]\]. Studies over the past two decades and more latterly in different regions of Nigeria have detected by serology testing and urine examination various serovars of the pathogenic *Leptospira interrogans*, such as Hardjo and Canicola, which have been implicated as the cause of human disease in other parts of the world \[[@bib18], [@bib20], [@bib21], [@bib22], [@bib23]\].

Infection with *Leptospira* has been associated with handling of wild and domestic animals, by which direct transmission may occur through the skin \[[@bib24]\]. Contact with pets and livestock in northern Nigeria poses an increased risk of *Leptospira* infection, which may be acquired via abraded skin during incautious handling of infected animals and their fluids or tissues \[[@bib18], [@bib19]\]. However, the contrary nature of observations from other countries suggests that there is no significant association between a person contracting leptospirosis and their close contact with livestock or other animals, implying a complex pattern of region- and setting-specific factors in infection risk \[[@bib25]\]. As investigations of leptospirosis in Nigeria are few in number \[[@bib25]\], clustered mainly to the north and conducted among typical risk groups \[[@bib18], [@bib19]\], it is uncertain if such heterogeneity in findings exists across all the different regions and varied settings nationally.

Other indirect sources of *Leptospira* infection include soil and water contaminated with urine or other body fluids from infected animals via which *Leptospira interrogans* may enter the human body through mucous membranes of the eyes and nose during activities such as bathing \[[@bib18], [@bib26]\]. Food-borne transmission may also be possible but current evidence suggests that this is rare \[[@bib27]\]. Heavy rainfall and flooding are also associated with outbreaks of leptospirosis around the world, in areas prone to overcrowding, inadequate waste disposal and poor hygiene \[[@bib26], [@bib28]\]. Such conditions are prevalent in Nigeria among the socioeconomically disadvantaged populations living in shanty towns, slums and relief camps \[[@bib29]\].

### 2.1.4. Q fever {#sec2.1.4}

Q fever in humans is caused by infection with *Coxiella burnetii*, a Gram-negative coccobacillus that is widely regarded as a potential agent of bioterrorism \[[@bib30]\]. Since the first description of the disease in slaughterhouse workers in Brisbane, Australia, in 1937, Q fever has become one of the bacterial zoonotic infections with a rising global distribution, especially in developing countries like Nigeria \[[@bib3], [@bib8]\]. *C*. *burnetii* has been reported at high serological prevalence in West African nations and has also been detected in veterinary studies in Nigeria, where 27% of the livestock and 0.1--14% of the ticks screened in Oyo State were infected \[[@bib31]\]; cattle, goats and sheep are most commonly infected and can serve as reservoirs for the bacterium. Several indications of local human infection have also been documented in the country ([Table 1](#tbl1){ref-type="table"}).

Consumption of raw or unpasteurized milk is a noted means of infection with *Coxiella burnetii* \[[@bib3]\]. Shedding of the bacterium was reported in milk samples from cattle in Zaria, Nigeria, in studies conducted between 1983 and 1984 \[[@bib32], [@bib33], [@bib34]\]. Associated with dairy farms, Q fever is a devastating zoonotic disease, especially within goat herds, and poses a threat even in industrialized nations such as the Netherlands, where it accounted for outbreaks from 2007 to 2010 \[[@bib3],[@bib35]\]. In Nigeria, among Fulani pastoralists who commonly practice dairy farming \[[@bib36], [@bib37], [@bib38]\], the possible risk to livestock of *C. burnetii* infection should be assessed.

The most important transmission route associated with *C. burnetii* infection in humans is inhalation of aerosolized organisms \[[@bib39]\]. Aerosols carrying *C. burnetii* may arise from its shedding by infected animals, usually during parturition or lactation, and are inhaled from vaginal mucus, placental fluid, urine and milk, as well as from contaminated environmental dust \[[@bib34], [@bib35]\]. Acquisition of Q fever via inhalation of contaminated aerosols or ingestion of raw milk or fresh dairy products has been reported in humans \[[@bib39], [@bib40]\], yet has not been described in Nigeria. A national assessment of the current risk of *C. burnetii* infection from environmental aerosols and dairy products may be justified, especially as around 90% of the milk produced in rural areas is consumed raw \[[@bib41]\]. Q fever is also known to pose the risk to immunodeficient individuals of a chronic disease condition \[[@bib34]\].

### 2.1.5. Rickettsiosis {#sec2.1.5}

Rickettsiae are obligate intracellular pathogens that have a wide global distribution and which commonly belong to the typhus group (TG) or spotted fever group (SFG). Studies have reported this group of Gram-negative coccobacilli as potential agents of zoonoses in Nigeria, detected by PCR and sequencing in 8.8% of dogs and 10.5% of their ectoparasites in Plateau, Kwara, Kaduna and Rivers States \[[@bib12], [@bib42]\]. *Rickettsia massiliae*, *R. conorii israelensis* and *R. africae*-like species have been identified as agents of bacterial zoonoses with possible ongoing transmission in the country.

*Rickettsia africae*, the causative agent of African tick-bite fever in humans, has been detected in several species of ticks, the arthropod vectors, from Nigeria and other West African countries \[[@bib12]\]. The aetiological agent of Mediterranean spotted fever is *R. conorii israelensis*, the presence of which in Nigeria was first reported in 2013 \[[@bib12]\]. *R. felis*, a prominent emerging rickettsial pathogen that is common in Senegal and Kenya \[[@bib43]\], has a largely unknown epidemiology in the rest of Africa, including Nigeria \[[@bib12], [@bib31], [@bib42], [@bib43]\].

### 2.1.6. Salmonellosis {#sec2.1.6}

Non-typhoidal salmonellosis is one of the most important enteric zoonoses globally \[[@bib44]\]. *Salmonella enterica* serovars Typhimurium and Enteritidis are reportedly the leading causes of sporadic outbreaks of human salmonellosis in Africa, a trend that is observed in Ibadan, the capital and most populous city of Oyo State, Nigeria, where these serovars collectively accounted for 62.5% of non-typhoidal *Salmonella* (NTS) infections in examined patients \[[@bib45], [@bib46], [@bib47]\]. Other less common serovars of the Gram-negative, flagellate, facultatively aerobic bacillus have a more geographically restricted distribution.

The rare *S. enterica* Hidudiffy was the predominant serovar in 95% of the 41 serotyped isolates in a study conducted in northern Nigeria but was absent in a similar investigation in the southern region of the country \[[@bib45], [@bib46], [@bib47]\]. This is believed to be attributable to such factors as variation in climate or farming systems between the two regions and may need verification \[[@bib45]\]. Other rare serovars that have been detected in Nigeria include *S. enterica* Apapa, Mouschaui and Vinohrady \[[@bib45], [@bib46], [@bib47], [@bib48]\]. In a recent large-scale surveillance program in Nigeria, *S. enterica* Eko was identified as a major serovar -- constituting 17.5% of 149 positive samples -- among the 17 different serotypes that are potentially being transmitted locally in north-eastern parts of the country \[[@bib47]\].

Zoonotic agents like *Salmonella* may be acquired from contact with animals, their dung and droppings, as well as via indirect transmission by ingesting contaminated food \[[@bib3]\]. This bacterium is a frequent cause of human food-borne bacterial gastroenteritis in both developing and developed regions of the world. Research performed on food products from markets in the Nigerian states of Sokoto, Plateau and Oyo associated *Salmonella* spp. with common transmission via contamination of poultry meat and eggs \[[@bib3], [@bib44], [@bib49], [@bib50], [@bib51]\]. A recent investigation in the north-east of the country also identified vegetables as a potential source of salmonellosis transmission, corroborating reports of the increasing global frequency of *Salmonella* outbreaks \[[@bib48]\]. *Salmonella* is also a leading cause of bacteraemia in at-risk populations including immunosuppressed individuals and infants across sub-Saharan Africa \[[@bib3], [@bib46]\].

### 2.1.7. Yersiniosis/Plague {#sec2.1.7}

Plague is an important re-emergent bacterial zoonosis caused by *Yersinia pestis*, one of the most extensively studied pathogenic bacteria, with current case reports restricted to Africa \[[@bib52]\]. Although earlier modelling of the geographical distribution of plague in Africa using 1970--2007 human plague data suggested that Nigeria has had no report of plague, subsequent examination of historical records from 1877 to 2008 indicated that plague has occurred in the country \[[@bib52], [@bib53]\]. The disease takes three main forms: pneumonic, generally contracted by inhalation of aerosolized organisms; septicaemic and bubonic, which are each spread via flea bites, contact with an infected animal, their dung and droppings, or through ingestion of contaminated food \[[@bib3], [@bib54]\].

Infection with *Y. pseudotuberculosis* in humans is rare, and the report of *Y. pseudotuberculosis* in Nigeria is possibly the first report of this Gram-negative, facultatively anaerobic coccobacillus in the tropics \[[@bib55]\]. Gastrointestinal yersiniosis, due to infection with the pathogenic *Y. enterocolitica*, was also documented in 5.8% of patients examined in the same study, conducted in Plateau State \[[@bib55]\]. Bioserotypes 1B/O:8, 2/O:5,27, 2/O:9, 3/O:3 and 4/O:3 constitute the pathogenic strains of *Y. enterocolitica* that are associated most commonly with human yersiniosis outbreaks \[[@bib56]\]. Similar strains have been reported from human gastrointestinal infections recorded in different parts of the country \[[@bib55]\].

*Y. enterocolitica* is a ubiquitous food-borne microorganism \[[@bib56]\]. Together with *Y. pseudotuberculosis*, it is known to occur predominantly in temperate zones \[[@bib55]\]. However, aspects of the epidemiology of food-borne yersiniosis in developing countries, such as contamination routes in food, remain poorly understood and require clarification \[[@bib56]\].

2.2. Animal reservoirs and the role of arthropods in transmission {#sec2.2}
-----------------------------------------------------------------

Livestock and animal reservoirs are recognized to contribute substantially to the continued transmission of bacterial zoonoses. This involves passive transmission through bites and scratches, as well as contamination of the environment \[[@bib26], [@bib30], [@bib57]\]. In addition, active transmission by vectors is implicated in bacterial zoonotic infections \[[@bib3]\]. The widespread distribution of zoonotic pathogens in arthropods as well as domestic and wild animals represents a large reservoir of these disease-causing agents ([Table 2](#tbl2){ref-type="table"}). As a result, there is a perpetually high risk of bacteria circulating between infected and susceptible animals, which carries the potential for spread to human hosts \[[@bib41]\].Table 2Transmission routes and availability of vaccines for important bacterial zoonoses in Nigeria.Table 2ZoonosisDirect/Indirect Transmission RoutesVectorsReservoirsLocal Availability of VaccinesBartonellosis[∗](#tbl2fnlowast){ref-type="table-fn"}Scratches or bites of cats and other animals[∗](#tbl2fnlowast){ref-type="table-fn"}Bat flies \[[@bib7]\]\
[∗](#tbl2fnlowast){ref-type="table-fn"}Human, cat and dog fleas \[[@bib54], [@bib76], [@bib78]\]\
Ectoparasites of rats and mice \[[@bib16]\]\
Sand flies, ticks \[[@bib3], [@bib12], [@bib16]\][∗](#tbl2fnlowast){ref-type="table-fn"}Cats \[[@bib58], [@bib59]\]\
[∗](#tbl2fnlowast){ref-type="table-fn"}Bats \[[@bib7]\]\
Rats and mice \[[@bib13], [@bib16]\]*Animal*: unknown\
*Human*: unknownBrucellosisHandling of animals \[[@bib17]\]\
Raw or unpasteurized milk \[[@bib17]\]Livestock and wild animals \[[@bib17]\]*Animal*: no known government policy since discontinuation in 1954 \[[@bib17]\]\
*Human*: unknownLeptospirosis[∗](#tbl2fnlowast){ref-type="table-fn"}Contact with animals or tissue and body fluid of animals via broken skin \[[@bib18]\]\
Food-borne \[[@bib18], [@bib26]\]\
Contaminated water and soil \[[@bib18], [@bib26]\][∗](#tbl2fnlowast){ref-type="table-fn"}Ticks \[[@bib26], [@bib74]\]Wild and domestic animals \[[@bib24]\]\
[∗](#tbl2fnlowast){ref-type="table-fn"}Rats, other rodents \[[@bib54]\]*Animal*: bacterins with limited success \[[@bib154]\]\
*Human*: unknownQ feverRaw or unpasteurized milk \[[@bib3]\]\
[∗](#tbl2fnlowast){ref-type="table-fn"}Inhalation of aerosolized organisms \[[@bib39]\]Ticks \[[@bib39], [@bib40]\]\
[∗](#tbl2fnlowast){ref-type="table-fn"}Filth flies \[[@bib30]\]Livestock \[[@bib34], [@bib40]\]*Animal*: unknown\
*Human*: unknownRickettsiosis[∗](#tbl2fnlowast){ref-type="table-fn"}Fleas \[[@bib54], [@bib75]\]\
Ticks \[[@bib31]\]\
[∗](#tbl2fnlowast){ref-type="table-fn"}*Ae.albopictus* \[[@bib81]\]\
[∗](#tbl2fnlowast){ref-type="table-fn"}*An.gambiae* \[[@bib83]\]Rodents \[[@bib54]\]*Animal*: unknown\
*Human*: unavailable \[[@bib155]\]SalmonellosisFood-borne \[[@bib3]\]\
Contact with animals\
Contaminated water \[[@bib3]\]Livestock, camels \[[@bib47]\]\
[∗](#tbl2fnlowast){ref-type="table-fn"}Household and captive reptiles \[[@bib45]\]\
Amphibians \[[@bib45]\]*Animal*: available for limited serovars in poultry \[[@bib156]\]\
*Human*: under development \[[@bib157]\]Yersiniosis/Plague[∗](#tbl2fnlowast){ref-type="table-fn"}Food-borne \[[@bib3]\]\
Contact with animals\
Inhalation of aerosolized organisms \[[@bib54]\][∗](#tbl2fnlowast){ref-type="table-fn"}Human and cat fleas \[[@bib52], [@bib54]\]\
Other fleas \[[@bib54], [@bib75]\]Rodents \[[@bib13], [@bib54]\]\
Livestock \[[@bib55]\]*Animal*: unknown\
*Human*: unknown[^3]

### 2.2.1. Animal reservoirs {#sec2.2.1}

Proximity to animals by virtue of a person\'s lifestyle or type of occupation is generally associated with the re-emergence and escalated risk of infection with bacterial zoonoses. This exposes -- among others -- farmers, nomads, hunters, veterinarians, pet dealers, wildlife workers, families with pets, butchers and abattoir workers to an increased likelihood of infection \[[@bib3], [@bib9]\]. Consequently, bacterial zoonoses are often regarded as occupational diseases in Nigeria \[[@bib9], [@bib18]\], where close contact with animals as well as exposure to their tissues and body fluids have been implicated as major risk factors for infection. A prime example is that of leptospirosis contracted during livestock slaughter and processing in abattoirs \[[@bib18]\].

It is estimated that approximately 20% of animal bites or scratches become infected, which is an important transmission route to humans for *Bartonella henselae*, the causative agent of cat-scratch disease. Cats are under-studied as potential reservoirs of locally acquired *Bartonella* infection in Nigeria despite their relative popularity as companion animals and the frequent occurrence of strays \[[@bib58], [@bib59]\], reportedly even in hospital premises in the north of the country \[[@bib60]\]. However, bats have been identified as reservoirs of *Bartonella* in Nigeria in a first finding reported in 2014, where four species of the bacterium were isolated in 15.5% of the *Micropterus* spp., *Eidolon helvum*, *Epomophorus* spp., *Rhinolophus* spp. and *Chaerephon nigeriae* bats sampled in the north-eastern city of Bauchi \[[@bib7]\]. This is similar to findings elsewhere in Africa, from Kenya, Ghana and Algeria \[[@bib61], [@bib62], [@bib63]\].

Bats are believed to serve as hosts of numerous pathogenic bacteria but most studies in Nigeria have chosen to focus on their being a source of infection of zoonotic viral agents. Accordingly, the primary aim of the recent bat surveillance by the Nigerian Health Ministry and partner agencies was to identify new and existing viruses in the flying mammals \[[@bib7], [@bib64]\]. Bats are known to live in proximity to humans in many Nigerian communities, where they are used for food, rituals and cultural practices, and thus they may play yet undiscovered roles in the transmission of the *Bartonella* pathogen and other zoonotic bacterial agents \[[@bib7], [@bib14]\].

*Bartonella* is also associated with rodents \[[@bib13]\]. These small mammals are common natural *Bartonella* reservoirs and close associations with humans due to overcrowded conditions in rural communities enhance infection transmission \[[@bib15], [@bib16]\]. Rodents are also reservoirs of other zoonotic bacteria like *Yersinia pestis* and *Rickettsia typhi*, the causative agent of murine typhus \[[@bib54]\]. *Y. pestis* has been detected in over 50 species of wild rodents in natural plague foci in Africa and across the globe \[[@bib13], [@bib54]\]. Rodents, notably rats, are also widely recognized as notorious reservoirs of *Leptospira interrogans*, usually spreading leptospirosis through their infected urine \[[@bib28]\]. A range of wild and domestic animals that serve as reservoirs of *Leptospira* spp. have been studied extensively for leptospirosis in Nigeria. Dogs, cattle, pigs, sheep and goats are commonly known worldwide to shed the bacterium in their urine, thereby contaminating the environment for several months or years after infection \[[@bib23], [@bib24], [@bib28]\]. However, very few attempts have been made to investigate the contribution of rodents to the epidemiology of the disease in Nigeria, with the last known report as long ago as 1990 \[[@bib28],[@bib65]\].

Livestock are important reservoirs of zoonotic infections like brucellosis and Q fever, for which ruminants provide a major source of human infections \[[@bib17], [@bib34], [@bib40]\]. A study in Oyo State indicated that cows may be reservoirs of Q fever in Nigeria \[[@bib31]\]. Livestock are also sources of food-borne zoonotic pathogens like *Y. pseudotuberculosis* and *Y. enterocolitica*, for which pigs, sheep, goats and cattle were identified as principal reservoirs of the pathogenic serotypes of human infection in Nigeria \[[@bib55]\]. Also, genomic analysis of *Salmonella enterica* Eko isolates, agents of salmonellosis, collected from different sources in Nigeria showed an association of camels with NTS outbreaks \[[@bib47]\]. This implicates camels, along with cattle, as a primary source of local human infections.

In developing countries, where the sources and transmission routes of salmonellosis are poorly understood, common food-producing animals are regarded as the primary reservoirs of *Salmonella*. This includes chickens, which studies in Nigeria, like elsewhere, identified as predominant reservoirs of a wide range of *Salmonella* serovars including Hadar and others known for their ability to colonize poultry \[[@bib46], [@bib48]\]. However, *Salmonella* transmission has also been associated with household reptiles like wall geckos and captive reptiles in Nigeria and across the world, suggesting the potentially emerging role of reptiles as reservoirs of the disease \[[@bib45]\]. The first reported case of human infection with *S*. *enterica* Apapa was linked to a pet lizard as the source of infection \[[@bib66]\]. Infections with this and other similar, rare serovars Jukestown, Mouschaui and Oritamerin were detected in Ibadan, where these bacteria were absent from chickens screened for salmonellosis. This suggests transmission by unverified infection sources such as household lizards that are common in the area, as previously these rare serovars have been linked to amphibians and reptiles \[[@bib45]\]. Molecular studies may be required to identify the sources associated with human infection, in order to establish key environmental reservoirs of infection.

### 2.2.2. Ticks {#sec2.2.2}

Tick-borne pathogens are recognized as important aetiological agents of human and animal diseases \[[@bib16]\]. Considered second only to mosquitoes as carriers of infectious agents \[[@bib16], [@bib67]\], ticks were originally identified in the 1930s as potential vectors of Q fever following isolation of the first strain of *Coxiella burnetii* from a Rocky Mountain wood tick, *Dermacentor andersoni* \[[@bib40]\]. Due to the frequent detection of *C. burnetii* in field-sampled ticks and experimental demonstration of vector competence in some tick species, it is currently considered that ticks act as transmitters of *C. burnetii* \[[@bib40]\].

The tropical bont tick, *Amblyomma variegatum*, has a proficient capacity to support transmission of *C. burnetii*, and it has been identified as a reservoir of *C. burnetii* and *Rickettsia africae* in Nigeria and Uganda \[[@bib39], [@bib68]\]. *A. variegatum* is the largest and most abundant tick species in Nigeria, posing a significant threat of Q fever transmission in Plateau, Nassarawa and Oyo States where *C. burnetii* has been isolated from collected ticks \[[@bib39]\]. There is a need, however, to interpret carefully the detection of *C. burnetii* in ticks until such time as a method for direct differentiation of *C. burnetii* and *Coxiella-*like bacteria is developed \[[@bib40]\]. Nonetheless, having followed the currently recommended protocols for *C. burnetii* screening, these findings are highly suggestive of a reservoir role for ticks in the transmission of Q fever in Nigeria.

Tick-borne rickettsiosis is also common in West Africa. *Rickettsia conorii israelensis* has been reported in Senegal \[[@bib69]\] and was first detected in Nigeria in the brown dog tick, *Rhipicephalus sanguineus* \[[@bib12]\]. *R. africae* was identified in cattle ticks, including those of the *Rhipicephalus* and *Hyalomma* genera, from a study that screened fed and questing ticks in Oyo State \[[@bib31]\]. This rickettsial species is frequently associated with *Amblyomma* ticks and less often with other potential vectors such as *Rhipicephalus annulatus* \[[@bib70]\]. However, *R. africae* was detected in feeding ticks only, which may have been acquired in a blood meal from an infected host \[[@bib31], [@bib70], [@bib71], [@bib72]\]. Thus, from these reports it is unclear which tick species are possible vectors of *R. africae* in Nigeria and there is a need for further elucidation of their vector competence. Another study in Nigeria in which *R. africae* was absent from dogs and brown dog ticks may point to a specific association of this zoonotic bacterium with cattle and game ticks \[[@bib12]\], as reported previously in South Africa \[[@bib73]\]. The presence of *Rickettsia massilae* and *R. rickettsii* in unfed ticks but not in their cattle hosts suggests that ticks are both a major vector and reservoir for this infectious agent in Nigeria \[[@bib31]\].

Similarly, in a study in Plateau State, Nigeria, *Bartonella* spp. DNA was detected in *R. sanguineus* but was absent from rodent hosts \[[@bib16]\]. This may indicate that the brown dog tick, whose role in *Bartonella* transmission has not been proven previously, may be a potential local reservoir. Comparison of the prevalence of bacterial pathogens in Nigerian feeding and questing ticks reiterates that their detection in the former does not establish vector competence, that is the ability of the tick to acquire, maintain and transmit a given species of bacterium \[[@bib31]\]. For instance, a higher prevalence of *C. burnetii* was observed in feeding *Rhipicephalus evertsi* ticks than in questing ticks collected from cattle in Oyo State, Nigeria. This stresses the need for experimental demonstration of vector competence in ticks that are able to maintain transstadial transmission of important zoonotic bacterial pathogens \[[@bib31]\].

Although the *in vitro* vector competence of tick species and the isolation of *Leptospira* spp. from them were both demonstrated several decades ago, it is a common misconception that the association of arthropods with leptospirosis transmission is unsubstantiated \[[@bib24], [@bib74]\]. However, *Leptospira* DNA was detected for the first time in ticks of the *Ixodes* genus collected from a flooded area of Poland, Eastern Europe \[[@bib74]\]. This may indicate a transition of *Leptospira*, aided by environmental changes, to adapt to new hosts and maintain transmission through them, as was noted previously for *L. interrogans* Hardjo serovar \[[@bib26]\]. Confirmation of this finding requires further investigation in other regions of the world where ticks are known to contribute to transmission of zoonotic bacteria. However, while there are areas of Nigeria that are prone to flooding, *Ixodes* ticks of medical and veterinary importance are not known to be present in these geographical zones \[[@bib16]\].

### 2.2.3. Fleas and other ectoparasites {#sec2.2.3}

The last decade has witnessed emerging reports on fleas, popularly known for transmitting the plague-causing *Yersinia pestis*, as potential contributors to the transmission of zoonotic agents like *Rickettsia typhi*, *R. felis* and *Bartonella henselae* \[[@bib54], [@bib75]\]. Thus, there is a need to investigate this haematophagous insect vector in Nigeria, a geographical area where information on the possible role of fleas in transmission of zoonoses is scanty. Performed in 2011, the first known screening of rodents and their ectoparasites for *Bartonella* in Nigeria detected species of the bacterium in 28% of the fleas, ticks, earwigs, and other arthropods found; some isolates represent known strains while others are of uncertain identity and require further characterization and evaluation for possible pathogenic status \[[@bib16]\]. The number of known vectors of *Bartonella* also continues to increase, with reports of other haematophagous arthropods such as sand flies, lice and mites as transmitters of bartonelloses between mammalian hosts, including humans \[[@bib3], [@bib12]\]. This calls for investigations in localities where the endemicity of these emerging vectors may overlap with the habitats of known reservoirs of *Bartonella* spp. in Nigeria.

Meanwhile, the human flea, *Pulex irritans*, which has been found to infest pets in Nigeria \[[@bib76]\], and the cat flea, *Ctenocephalides felis*, have been associated with the recently re-emerged *Bartonella quintana* infection in some parts of the developed world \[[@bib54]\]. Cat fleas and some other flea species are also regarded as major reservoirs and biological vectors of *R. felis*, capable of horizontal and vertical transmission of this pathogen. However, contrary reports from Senegal suggest that cat fleas do not contribute to local transmission of *R. felis* despite the high prevalence of human infections \[[@bib54], [@bib77]\]. Cat fleas, found on both cats and dogs, are also responsible for the transmission of *B. henselae* \[[@bib3], [@bib54], [@bib78]\].

Dog fleas like *Ctenocephalides canis* have been associated with *B. henselae* elsewhere globally \[[@bib79]\]. Although these ectoparasites have equally been reported at high prevalence in Nigeria, where pet dogs are common and share close bonds with humans, the potential roles of dog fleas in the local transmission of zoonotic infection is poorly understood in the country \[[@bib76], [@bib80]\]. It is also believed that any species of flea is capable of transmitting *Y. pestis* under appropriate conditions, and that *P. irritans* may play an important role in human-to-human transmission of the plague \[[@bib54]\]. Often regarded as a mere nuisance due to earlier reports of vector incompetence for *Y. pestis*, cat fleas were suspected to account for a plague outbreak in Uganda \[[@bib54]\]. Yet, while the human flea and other flea species are known to be found on pets in Nigeria, there is currently no record associating fleas with local transmission of *Y. pestis* \[[@bib52]\].

### 2.2.4. Emerging role of mosquitoes and other flies {#sec2.2.4}

Recent findings indicate that mosquitoes may have emerged as vectors of *Rickettsia* spp. in West Africa. *R. felis* was detected in the Asian tiger mosquito, *Aedes albopictus*, in Gabon, a country to the south of Nigeria, at infection loads similar to those observed in the cat flea, which is currently regarded as the primary vector \[[@bib81]\].

A species invasive to Nigeria, since its discovery in Delta State *Ae. albopictus* now dominates over the native yellow fever mosquito, *Ae. aegypti*. Recent analysis reveals a wide distribution across the south of the country \[[@bib82]\]. *Ae. albopictus* was originally identified in Nigeria in 1991 and first reported in Gabon in 2006. While its role in transmitting arboviral infections is a major focus of investigation in Nigeria its possible association with *R. felis* does not appear to be a research priority \[[@bib82]\]. In Senegal, a West African country where *Ae. albopictus* is not known to occur, the major African malaria vector, *Anopheles gambiae*, presents a risk of rickettsial infection as *R. felis* and a new *Rickettsia* sp. were detected in *An. gambiae* and *An. melas* \[[@bib83]\]. This zoonotic bacterial agent was also detected in *Anopheles* vectors in Gabon and Cote d'Ivoire.

Similar observations suggesting a possible role for mosquitoes in transmission of rickettsiae were documented in China, where *R. felis* and a species closely related to the new *Rickettsia* species reported in Senegal and Cote d'Ivoire were also detected in *An. sinensis* and *Culex pipiens* \[[@bib84], [@bib85]\]. The conclusions drawn from these studies add to the growing evidence implicating mosquitoes from a range of genera in the transmission of SFG rickettsiae infections in different parts of the world where they are endemic. It is particularly noteworthy that in China the rickettsial organisms were also detected in the plant-feeding male *Cx. pipiens*, revealing a capacity for this mosquito species to maintain rickettsial infection by vertical transovarian transmission.

These findings are strong indications that mosquito transmission may play a part in the high risk of infection with *R. felis* that was reported in Senegal where transmission via fleas is absent \[[@bib43], [@bib77]\]. However, the potential role of mosquito species in the transmission of rickettsial zoonoses in Nigeria are not yet understood or described. This can also be said of other arthropods, especially filth flies such as the housefly, *Musca domestica*, which have been identified as potential mechanical vectors capable of transmitting zoonotic infectious agents like *Coxiella burnetii* in other parts of the world \[[@bib30], [@bib86]\]. Blood-feeding bat flies have also been proposed as possible contributors to local transmission of bartonellosis in Nigeria \[[@bib7]\].

2.3. Human health implications, surveillance and public health interventions {#sec2.3}
----------------------------------------------------------------------------

### 2.3.1. Known challenges {#sec2.3.1}

The prevalence of infection in surveillance indicators such as arthropods and other animal hosts is commonly used to assess the risk of the local transmission of pathogens to humans. Hence, within a defined geographical area, the distribution and abundance of ticks and other haematophagous vectors is considered to determine the epidemiology of vector-borne infections \[[@bib16], [@bib87]\]. Studies in Nigeria have shown possible ongoing transmission of emerging and re-emerging bacterial zoonoses with which a number of potential animal reservoirs and vectors have been associated ([Table 2](#tbl2){ref-type="table"}), while limited assessments of infection risk have also been undertaken \[[@bib41]\]. These investigations represent the few efforts at surveillance of bacterial zoonoses in the country. Human infection data also constitute an important surveillance indicator of infection risks \[[@bib87]\]. However, these are essentially lacking in Nigeria for bacterial zoonoses such as bartonellosis, brucellosis and Q fever for which little is known about rates of infection ([Table 1](#tbl1){ref-type="table"}). Further research is required to provide comprehensive information on clinical cases and prevailing infection rates \[[@bib17], [@bib41]\]. Serological evidence of human brucellosis has been reported but no details of *Brucella* isolation from patients in Nigeria are available \[[@bib17]\].

Estimates of vector-borne infectious diseases burden in low- and middle-income countries tend to focus on malaria and dengue while bacterial zoonoses are largely overlooked \[[@bib8]\]. This is despite reports from Nigeria that warrant the assessment of disease burden in humans of *Coxiella burnetii, Rickettsia conorii israelensis* and other pathogenic zoonotic bacteria, plus consideration of the public health implications associated with their various animal reservoirs and vectors in the country \[[@bib16], [@bib31]\]. In Nigeria, brucellosis is frequently misdiagnosed as malaria \[[@bib17]\], a common occurrence in the case reporting of bacterial zoonoses in Africa and other malaria-endemic regions \[[@bib88]\]. A recent study in northern Tanzania showed that clinical cases of bacterial zoonoses such as leptospirosis, brucellosis, rickettsioses and Q fever may often be excluded or misdiagnosed as the more prevalent malaria in areas of its endemicity \[[@bib5]\]. Following a steady decline in malaria burden, there has been a gradually increasing awareness of bacterial zoonoses as major causes of FUO in sub-Sahara Africa \[[@bib5], [@bib89], [@bib90]\]. In Abuja, Nigeria\'s centrally located capital city, where the historical over-diagnosis of malaria is suspected, non-typhoidal *Salmonella* infection was reported in the aetiological diagnoses of febrile cases \[[@bib91]\]. In contrast, for an FUO case in south-east Nigeria important aetiological agents may have been overlooked and presumptive malaria treatment was adopted, a common practice in this area that has also been reported for the case management of febrile paediatric patients \[[@bib92], [@bib93]\].

Access to diagnostic tools is a conspicuous challenge. The multiple causes of fever are difficult to distinguish clinically and hence many cases of FUO in low-resource contexts may be attributed to either lack of access to or limited provision of suitable medical microbiology laboratory services \[[@bib8]\]. In the case of brucellosis, for instance, serological diagnostic tools are typically sophisticated as they were developed in high-income countries long after the disease was eradicated. As a consequence, these are better suited to well-equipped laboratories that are extremely scarce in resource-limited settings, especially for point-of-care needs \[[@bib17]\]. It was reported that Nigerian abattoir workers who eventually received a correct diagnosis of *Brucella* infection frequently complained of continued treatment for malaria despite their condition failing to improve \[[@bib17]\]. This is a good example of the actuality that patients in Africa infected with bacterial zoonoses are likely to be discharged from hospital without receiving a correct diagnosis and thus the appropriate specific treatment.

It is also evident that clinicians often lack information on the local epidemiology of causes of severe febrile illness. As a result, internationally set management guidelines and disease control programs currently have insufficient data to set local priorities for prevention \[[@bib8]\]. Focus on a wide range of potential causes of FUO, especially zoonotic infections, has been recommended for patient management and disease control in resource-limited settings \[[@bib5]\]. It is expected that better national surveillance and reporting will improve disease control strategies, whereby clinicians play a pivotal role in the effective management of zoonoses with enhanced differential diagnoses \[[@bib3]\].

Notable antimicrobial resistance of public health concern in food-borne zoonoses such as salmonellosis has been reported in Nigeria \[[@bib45], [@bib94]\], but the indiscriminate use of antibiotics as animal growth promoters remains a common practice and calls for stringent regulations to be imposed. Isolates of *Salmonella enterica* Typhimurium similar to the multidrug-resistant ST313 clone of sub-Sahara Africa, as well as other strains resistant to antimicrobials such as tetracycline and sulfamethoxazole, were identified in Ibadan \[[@bib45]\]. This was attributed to the non-selective use of antibiotics at therapeutic or subtherapeutic levels, a practice that was observed in cattle examined from the same locality in which residual doses of oxytetracycline and penicillin-G were detected \[[@bib95]\]. Of related concern, recent investigation in south-west Nigeria showed an increasing trend in the use of fluoroquinolones, tetracyclines, beta-lactams/aminoglycosides and macrolides for questionable purposes ranging from animal disease management to livestock growth promotion \[[@bib94]\]. Meanwhile, other countries led by the USA have prohibited the use of quinolones as growth promoters in poultry feed due to the public health implications of similarities of pharmaceuticals used to treat human and animal infections \[[@bib3], [@bib94]\]. In Nigeria, there is no such strict legislation governing antibiotic residues in animal tissues, while there is inadequate emphasis on regulation of veterinary drugs for human and animal health safety as the responsibility of the local food and drug administration agency \[[@bib96]\].

### 2.3.2. A One Health approach {#sec2.3.2}

Although approaches to public health interventions for zoonotic infections in Nigeria have been proposed, a case for disease prioritization and consequently, investment and funding, will depend on evaluation of both human and animal health impacts \[[@bib11], [@bib41]\]. Early reports identified the importance of the joint endeavours of medical and veterinary professionals to the control of zoonoses affecting public health and animal welfare in Nigeria \[[@bib1]\]. Subsequently, the role of key stakeholders in the Ministries of Agriculture, Health and Information to enhance the health of both human and animal populations has been emphasized \[[@bib9], [@bib41]\]. The complex interrelations and interdependence of human, animal and environmental health has given rise to the 'One Health' concept ([Figure 1](#fig1){ref-type="fig"}). This advocates for the collaborative efforts of professionals from multiple disciplines, such as clinicians, veterinarians and environmentalists, working at state, national and international levels in order to achieve better public health outcomes \[[@bib2]\]. While there is increasing global support for nations to adopt the One Health approach, in Nigeria there is a failure to recognize interdisciplinary commonalities, especially between clinicians and veterinarians. This remains a significant challenge to progress in tackling zoonotic infections in the country despite rising awareness of misdiagnosed undifferentiated fever \[[@bib2], [@bib41]\]. In 2009, the US Centers for Disease Control and Prevention launched the Animal-Human Interface Project (AHIP) in Nigeria, providing consultations and technical training to facilitate the progress of in-country One Health \[[@bib64]\]. Several collaborative projects were fostered by the AHIP along with partner agencies in Nigeria to investigate a range of zoonotic infections; however, the predominant attention was focused on viral diseases. This is possibly a reflection of the assertion that viral zoonoses are capable of influencing greater political and economic responses, as exemplified by the recent Ebola outbreaks in Nigeria and DR Congo \[[@bib97], [@bib98]\] as well as the current COVID-19 global pandemic.Figure 1Schematic representation of the One Health concept.Figure 1

Vector-borne diseases are a major target of the One Health approach. Together with other endemic infectious diseases these have increased in global incidence during the past two decades. A large number of vector-borne infections have emerged in regions where they were hitherto unknown \[[@bib3]\]. In regard to Nigeria, this heightened public health threat emphasizes a need for up-to-date and authentic information on bacterial zoonoses, especially for vector-borne zoonotic agents that have been shown in recent times to emerge in novel vectors, such as *Rickettsia felis* in mosquitoes \[[@bib76]\]. A correlation exists between the epidemiology of *R. felis* infection and malaria in sub-Sahara Africa \[[@bib71]\]. This indicates an increased risk of rickettsial zoonoses in this region compared to others. Mosquito species identified as potential vectors of *R. felis* in other West African nations as well as in China, and which may be responsible for its transmission in Senegal \[[@bib83]\], are known to be endemic to Nigeria \[[@bib77], [@bib81], [@bib82], [@bib83], [@bib84], [@bib85]\]. Although human rickettsial infections have yet to be confirmed in Nigeria, as a precautionary measure they are highlighted as a source of potential disease for incoming travelers \[[@bib99]\]. Another pathogenic agent of bacterial zoonosis, *Yersinia pseudotuberculosis*, was described recently for the first time in Nigeria \[[@bib55]\], which indicates an extension of its geographical range into the country.

In the One Health strategy, a major recommendation for food-borne zoonoses is farm-level intervention ([Figure 1](#fig1){ref-type="fig"}). This includes routine vaccination, immune stimulants and probiotic feed additives for animal health management as well as other initiatives including animal welfare policies and measures to curb antimicrobial resistance \[[@bib3]\]. However, successful adoption of such interventions in Nigeria is hampered by setbacks such as problems of sustainability due to the dismantling of disease control programs \[[@bib41]\]. Moreover, culling of livestock with subsequent compensation of farmers, a strategy that has proved beneficial to zoonosis control in the developed world, has been ineffective in Nigeria. This is because farmers, notably Fulani pastoralists, are not willing to cooperate when infectious disease control involves deliberate loss of their herds \[[@bib41]\]. Yet, changing lifestyles among settled Fulani communities, including healthcare-seeking attitudes and practices, may lead possibly to increased receptiveness of this influential group to comply with animal health interventions in the future \[[@bib37]\].

### 2.3.3. Under-reporting abets under-recognition {#sec2.3.3}

The risk of infection with bacterial zoonoses is particularly high in rural communities and among those in close contact with wild animals or livestock. Unfortunately, however, zoonoses affecting primarily subsistence farmers and low-income residents of non-urban localities are not assigned a defined control or prevention program in Nigeria\'s national healthcare scheme \[[@bib11], [@bib41]\]. Under-reporting of case numbers and under-estimation of the human impact of a disease are recognized as factors in it being devalued for health policy prioritization and investment for intervention \[[@bib11]\].

In sub-Sahara Africa, where hospitals and healthcare clinics typically are not readily accessible to the most affected people, accurate statistics on morbidity and mortality resulting from bacterial zoonoses are difficult to obtain \[[@bib11]\]. *Bartonella* spp. have been associated with endocarditis and neuroretinitis in other parts of the world, such as Peru \[[@bib13]\], but there is no known link to human disease for the identical strains which have been isolated in Nigeria \[[@bib12]\]. In Senegal, where levels of detection of *C. burnetii* in reservoir cattle are lower than those in Nigeria, seroprevalence rates in humans are reportedly as high as 21.4%--51% \[[@bib34]\], suggesting that these may be even surpassed in Nigeria \[[@bib31]\]. However, this possibility needs to be substantiated through future investigations. An exception to the systemic trend to under-report is food-borne yersiniosis caused by the pathogenic *Y. enterolitica*. This is diagnosed among Nigerian communities at levels similar to those reported by developed nations, in all situations being associated primarily with chronic gastrointestinal illness and glomerulopathy \[[@bib56], [@bib100]\].

A case of human leptospirosis in Plateau State and a localized outbreak among dogs and their handlers in a kennel in Abuja have been reported \[[@bib19], [@bib20]\], yet no known survey of leptospirosis as a cause of febrile illness has been conducted in the country \[[@bib28]\]. In 2006, zoonotic infections including leptospirosis, brucellosis and salmonellosis were identified as under-recognized and under-reported in Nigeria \[[@bib101]\]. The true extent of the health impacts of these zoonoses, particularly in the human population, was unknown. Moving forward more than a decade, the situation is still largely unchanged for most of these diseases, exemplified by brucellosis \[[@bib17]\]. Consequently, under-appreciation of pathogenic agents like zoonotic bacteria in Nigeria contributes to the lack of an integrated approach to avert morbidity and mortality from febrile illnesses. This relative neglect contrasts starkly with pneumonia and diarrhoea, for instance, each of which is the focus of a well-coordinated global effort across most of the range of its causative pathogens \[[@bib4], [@bib5]\].

Understanding the case distribution as well as health impacts of zoonotic diseases is an important step in planning and implementing effective control and prevention measures \[[@bib102]\]. In developing countries, coordinated epidemiological systems for national surveillance of zoonotic infections are generally inadequate despite indications of a substantial burden of disease \[[@bib46], [@bib49]\]. A large-scale study was carried out in 2009--2011 to provide the first comprehensive surveillance of salmonellosis in human and non-human samples in Nigeria but this was limited to only one state in the north-east \[[@bib103]\], so is unlikely to be representative of the entire country since some serovars of NTS are commonly known to have a geographically restricted distribution \[[@bib47]\]. Reports on human brucellosis have concentrated on the classic at-risk population and thereby neglected other potentially susceptible groups \[[@bib17]\]. As a consequence, around a century since its original identification in Nigeria, very little is understood of *Brucella* regarding accurate evaluation of its zoonotic potential and thus to inform the roll-out of relevant control measures. A vaccination program was discontinued in 1954, yet brucellosis remains a national health concern \[[@bib17]\]. Using global burden of human disease methodology, Nigerian policymakers depend on unreliable metrics obtained mostly from scant data from other regions, thereby contributing to a systemic under-valuation of zoonotic diseases nationally \[[@bib11]\]. The resultant lack of resource commitment to health issues in Nigeria and other developing countries presents an ongoing challenge to interdisciplinary One Health collaborations and partnerships that aim to harness evaluation and analysis of health status to enhance public health surveillance and disease control \[[@bib41]\].

### 2.3.4. Cost-effective strategies {#sec2.3.4}

Cost-effectiveness of interventions has been proposed as an alternative criterion to overall burden of disease to determine priority-setting for investment in disease control \[[@bib104]\]. The presence of multiple reservoir hosts was highlighted as a major hurdle to the eradication of zoonoses in Nigeria. Hence, interventions targeted extensively at animal reservoirs and accompanied by promotion of public awareness have been suggested as cost-effective strategies to control bacterial and non-bacterial zoonoses in the country \[[@bib9], [@bib41]\]. Investing resources into the surveillance and treatment of animal populations rarely enjoys robust and influential support in most of the developing world despite the rewards of improved human and animal health in promoting food security and eradicating poverty \[[@bib11]\]. The costs of intervention for zoonotic diseases can seem excessive when balanced against the public health benefits alone. Vaccines have either not been developed or are unavailable locally in Nigeria ([Table 2](#tbl2){ref-type="table"}). It is believed that evidence of disease burdens imposed on communities by zoonotic diseases combined with a demonstration of the cost-effectiveness of integrated control can strengthen the case for a One Health approach to endemic zoonotic disease control \[[@bib11]\]. There are strong indications that investment in animal health interventions and veterinary care will facilitate protection of humans against exposure to transmission of zoonotic infections from animal hosts \[[@bib41], [@bib105]\].

The full benefits of a multidisciplinary analysis covering health and economic factors across all sectors will easily outweigh costs and enable the health sector to present arguments to policymakers based on the rate of return on investment rather than on the impact on disability life-adjusted years \[[@bib11]\]. It is therefore recommended that interventions against zoonotic infections in Nigeria should be viewed as investments in human capital and form an integral part of poverty reduction plans \[[@bib11]\].

3. Conclusions {#sec3}
==============

In order to improve human and animal health security in Nigeria, there is a need for cost-effective strategies that will increase the prioritization of bacterial zoonoses in health policies and encourage investments in health interventions. Current epidemiological data and surveillance of bacterial zoonoses in the country are inadequate, a circumstance that obstructs the progress of One Health development. This constitutes a setback to collaborative engagements between relevant disciplines and qualified professionals such as veterinarians and clinicians. While various species and strains of common and rare pathogenic zoonotic bacteria have been identified in vectors and animal reservoirs in Nigeria, for most of these there is very limited information available on their potential impact on human health. Recent research indicating the emergence of some zoonotic bacterial pathogens in hitherto unknown vectors and in new geographical locations calls for re-assessment of their previously recorded national distribution or officially listed non-occurrence. There is a clear and significant knowledge gap in regard to bacterial zoonoses in Nigeria, the closing of which is crucial to the success of future control and preventive public health interventions. The implementation of such measures will likely lead to a reduction in local incidence rates of patients with undifferentiated fever.
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[^1]: NTS = Non-typhoidal *Salmonella* spp.

[^2]: Limited accessible data.

[^3]: Notable emerging and/or under-studied transmission routes in Nigeria.
